triptolide has been researched along with Astrocytosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, L; Gao, L; He, C; Qiu, Y; Su, Z; Yuan, Y; Zhu, Y | 1 |
| Cai, DF; Chen, YP; Gao, JP; Li, WW; Sun, S | 1 |
2 other study(ies) available for triptolide and Astrocytosis
| Article | Year |
|---|---|
Triptolide promotes spinal cord repair by inhibiting astrogliosis and inflammation.
Topics: Animals; Animals, Newborn; Astrocytes; Cells, Cultured; Disease Models, Animal; Diterpenes; Epoxy Compounds; Exploratory Behavior; Glial Fibrillary Acidic Protein; Gliosis; Immunosuppressive Agents; Inflammation; Janus Kinase 2; Male; Neurofilament Proteins; Phenanthrenes; Psychomotor Performance; Pyramidal Tracts; Rats; Rats, Sprague-Dawley; Signal Transduction; Spinal Cord Injuries; STAT3 Transcription Factor | 2010 |
Triptolide protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats: implication for immunosuppressive therapy in Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Biomarkers; CD11b Antigen; Cell Count; Cell Survival; Disability Evaluation; Diterpenes; Dopamine; Encephalitis; Epoxy Compounds; Gliosis; Herbicides; Immunosuppression Therapy; Immunosuppressive Agents; Male; Microglia; Neurons; Parkinsonian Disorders; Phenanthrenes; Rats; Rats, Sprague-Dawley; Substantia Nigra; Treatment Outcome; Tyrosine 3-Monooxygenase | 2008 |